WASHINGTON (MedPage Today) — Employees at the Department of Health and Human Services (HHS) owed a total of $37.3 million in back taxes at the end of 2009, according to a report published online Thursday in the Washington Post.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA is requiring the makers of some gadolinium-based contrast agents (GBCAs) to add new warnings to the drug label to minimize the development of nephrogenic systemic fibrosis (NSF) in some patients with kidney dysfunction.
No Comments »
Filed under: General Health News
(MedPage Today) — Transferring trauma patients from one hospital to another, only to discharge them that day or the next, is a relatively infrequent occurrence but is still a costly burden on the medical system, researchers said.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A federal appeals court has ruled that government funding of embryonic stem cell (ESC) research can resume while it mulls a federal district court judge’s ruling blocking the funds.
No Comments »
Filed under: General Health News
(MedPage Today) — School and day care closures due to the 2009 pandemic of H1N1 flu weren’t a big problem for most parents, researchers found.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has sent letters to five manufacturers of electronic cigarettes warning that they are in violation of federal law by claiming their products help smokers quit.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA is requiring the makers of some gadolinium-based contrast agents (GBCAs) to add new warnings to the drug label to minimize the development of nephrogenic systemic fibrosis (NSF) in some patients with kidney dysfunction.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The FDA has sent letters to five manufacturers of electronic cigarettes warning that they are in violation of federal law by claiming their products help smokers quit.
No Comments »
Filed under: Pharmacy News
Resverlogix Corp. announces that the Company’s Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.
No Comments »
Filed under: Pharmacy News
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its 2010 fiscal year ended June 30, 2010.
No Comments »
Filed under: Pharmacy News
